1. 505 Clinical evidence of intra-tumoral immune activation and tumor targeting with RG, a CEA-targeted engineered IL-2 immunocytokine. (September 2015) Authors: Tabernero, J.; Homicsko, K.; Schellens, J.H.; Hoekstra, O.; Van der Veen, L.; Melero, I.; és, G. Argil; Mau-Sorensen, M.; Angevin, E.; Joensuu, H.; Van Brummelen, E.; van Oordt, C.W. Menke-van der Houven; Nayak, T.; Romagnoli, S.; Reis, B.; Brossard, S. Soehrman; Evers, S.; Saro, J.; Verheul, H.;... Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗